Jump to main content

yr 〜
yr

Search results 2

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
Digital博士論文
小谷, 大輔2022-03-24
National Diet Library
  • Subject HeadingMetastatic colorectal cancer CAPOXIRI Triplet Bevacizumab FOLFOXIRI
  • Note (General)...nd irinotecan (CAPOXIRI) combination p......dose levels of CAPOXIRI (fixed dose of......ons: The RD of CAPOXIRI plus bevacizumab was 200, 130...

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study

Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
Digital博士論文
小谷, 大輔
Available onlineOther Libraries in Japan
  • Summary, etc....nd irinotecan (CAPOXIRI) combination p......dose levels of CAPOXIRI (fixed dose of......ons: The RD of CAPOXIRI plus bevacizumab was 200, 130...
  • Subject HeadingMetastatic colorectal cancer CAPOXIRI Triplet Bevacizumab FOLFOXIRI

Reached to the end of result.

RSS